We are live on
!
Find out more
Edwards Lifesciences
1,282 hedge funds and large institutions have $40.3B invested in Edwards Lifesciences in 2026 Q1 according to their latest regulatory filings, with 111 funds opening new positions, 454 increasing their positions, 458 reducing their positions, and 117 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $43B → $40.3B (-$2.7B)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
34% less call options, than puts
Call options by funds: $146M | Put options by funds: $223M
Holders
1,282
Holding in Top 10
6
Calls
$146M
Puts
$223M
Top Buyers
| 1 | +$419M | |
| 2 | +$384M | |
| 3 | +$333M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$182M |
| 5 |
Neuberger Berman Group
New York
|
+$167M |
Top Sellers
| 1 | -$353M | |
| 2 | -$353M | |
| 3 | -$324M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$171M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$139M |